# Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer

> **NCT04131634** · PHASE2 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Urothelial Cancer

## Interventions

- **RADIATION:** Stereotactic Ablative Radiation

## Key facts

- **NCT ID:** NCT04131634
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-16
- **Primary completion:** 2020-12-17
- **Final completion:** 2021-06-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The trial has terminated due to changes in standard of care since its activation, which has led to poor accrual.
- **Last updated:** 2021-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04131634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04131634, "Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04131634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*